On August 3, Lunit, a medical artificial intelligence (AI) company, announced that it has signed a series of contracts to supply AI and digital solutions with major medical institutions in the UK and US.


Lunit Signs AI Solutions Supply Contracts with Major Medical Institutions in the UK and US View original image

In the UK, Lunit has secured GenesisCare UK, which operates more than 10 cancer and diagnostic centers nationwide, as a new client. The company will supply Analytics and Scorecard, solutions for mammography quality and operation management, and Lunit INSIGHT MMG and DBT, its AI-based breast cancer diagnostic solutions, establishing an integrated screening system that covers everything from imaging quality management to AI interpretation.


In the United States, two new clients have signed on: VA Tulsa, part of the federal Department of Veterans Affairs (VA), and DeTar Healthcare System, a general hospital in Texas. VA Tulsa is a large medical center providing healthcare for approximately 36,000 veterans annually. Both institutions will be supplied with Patient Hub, which supports patient management, and Risk Pathways, which helps provide customized screenings for high-risk groups.


Lunit previously, through its subsidiary Lunit International (formerly Volpara), signed a five-year contract with the U.S. Defense Health Agency (DHA) in 2024, valued at 7.3 million dollars (approximately 10.6 billion won). The company explained that with this new VA contract, it will further strengthen its presence in the U.S. public healthcare market.



Beomseok Seo, CEO of Lunit, stated, "This contract demonstrates that global healthcare institutions' demand is rapidly growing for end-to-end platforms covering the entire cancer screening process, going beyond AI imaging interpretation." He added, "We will continue to expand our presence in the global healthcare market with a product mix that combines imaging AI and screening operation solutions."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing